HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica.

AuthorsKeisuke Hagihara, Ichiro Kawase, Toshio Tanaka, Tadamitsu Kishimoto
JournalThe Journal of rheumatology (J Rheumatol) Vol. 37 Issue 5 Pg. 1075-6 (May 2010) ISSN: 0315-162X [Print] Canada
PMID20439532 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • tocilizumab
Topics
  • Aged
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents (therapeutic use)
  • Female
  • Humans
  • Polymyalgia Rheumatica (therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: